The molecular characteristics of this cohort were fairly representative of conventional colorectal carcinoma, with frequent alterations in KRAS (74%), TP53 (71%), and APC (51%); The majority of tumors (95%) were microsatellite stable. The gene discussed is TP53; the disease is colorectal carcinoma.